International Journal of Pediatric Otorhinolaryngology
Volume 74, Issue 4 , Pages 343-346 , April 2010

Treatment patterns of pediatric nontuberculous mycobacterial (NTM) cervical lymphadenitis as reported by nationwide surveys of pediatric otolaryngology and infectious disease societies

  • E.F. Pilkington

      Affiliations

    • Oregon Health & Science University, Portland, OR, United States
    • Corresponding Author InformationCorresponding author at: Division of Infectious Diseases, Oregon Health and Science University, 3181 Sam Jackson Park Rd., L-457, Portland, OR 97239, United States.
    • ,
  • C.J. MacArthur

      Affiliations

    • Oregon Health & Science University, Portland, OR, United States
    • ,
  • S.E. Beekmann

      Affiliations

    • University of Iowa, Iowa City, IA, United States
    • ,
  • P.M. Polgreen

      Affiliations

    • University of Iowa, Iowa City, IA, United States
    • ,
  • K.L. Winthrop

      Affiliations

    • Oregon Health & Science University, Portland, OR, United States
    • Corresponding Author InformationCorresponding author at: Division of Infectious Diseases, Oregon Health and Science University, 3375 SW Terwilliger Blvd., CEI, Portland, OR 97239, United States. Tel.: +1 503 494 7890; fax +1 503 494 4286.

Received 15 June 2009 ,Revised 24 August 2009 ,Accepted 26 August 2009.

References 

  1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 2007;175:367–416
  2. McNabb AD, Eisler K, Adlie M, Amos M, Rodrigues G, Stephens WA, et al. Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of mycobacterium species isolated from clinical sources. J. Clin. Microbiol. 2004;42:3000–3011
  3. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990's. Clin. Microbiol. Rev. 2003;2:319–354
  4. Grange JM, Yates MD, Poznisk A. Bacteriologically confirmed non-tuberculous mycobacterial lymphadenitis in southeast England: a recent increase in the number of cases. Arch. Dis. Child. 1995;72:516–517
  5. Vu TT, Daniel SJ, Quach C. Nontuberculous mycobacteria in children: a changing pattern. J. Otolaryngol. 2005;34(Suppl. 1):S40–S44
  6. Méndez Echevarría A, Baquero Artigao F, García Miguel MJ, Romero Gómez MP, Alves Ferreira F, Del Castillo Martín F. Nontuberculous mycobacterial lymphadenitis. Ann. Pediatr. (Barc.). 2007;66:254–259
  7. Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin. Infect. Dis. 1995;20:954–963
  8. Stewart MG, Starke JR, Coker NJ. Nontuberculous mycobacterial infections of the head and neck. Arch. Otolaryngol. Head Neck Surg. 1994;120:873–876
  9. Tunkel DE, Romaneschi KB. Surgical treatment of cervicofacial nontuberculous mycobacterial adenitis in children. Laryngoscope. 1995;105:1024–1028
  10. Hazra R, Robson CD, Perez-Atayde AR, Husson RN. Lymphadenitis due to nontuberculous mycobacteria in children: presentation and response to therapy. Clin. Infect. Dis. 1999;28:123–129
  11. Lindeboom JA, Kuijper EJ, Bruijnesteijn van Coppenraet ES, Lindeboom R, Prins JM. Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. Clin. Infect. Dis. 2007;44:1057–1064
  12. Rahal A, Abela A, Arcand PH, Quintal MC, Lebel MH, Tapiero BF. Nontuberculous mycobacterial adenitis of the head and neck in children: experience from a tertiary care pediatric center. Laryngoscope. 2001;111:1791–1796
  13. Danielides V, Patrikakos G, Moerman M, Bonte K, Dhooge C, Vermeersch H. Diagnosis, management and surgical treatment of non-tuberculous mycobacterial head and neck infection in children. ORL J. Otorhinolaryngol. Relat. Spec. 2002;64:284–289
  14. Fraser L, Moore P, Kubba H. Atypical mycobacterial infection of the head and neck in children: a 5-year retrospective review. Otolaryngol. Head Neck Surg. 2008;138:311–314
  15. Albright JT, Pransky SM. Nontuberculous mycobacterial infections of the head and neck. Pediatr. Clin. N. Am. 2003;50:503–514
  16. Wei JL, Bond J, Sykes KJ, Selvarangan R, Jackson MA. Treatment outcomes for nontuberculous mycobacterial cervicofacial lymphadenitis in children based on the type of surgical intervention. Otolaryngol. Head Neck Surg. 2008;138:566–571
  17. Sigalet D, Lees G, Fanning A. Atypical tuberculosis in the pediatric patient: implications for the pediatric surgeon. J. Pediatr. Surg. 1992;27:1381–1384
  18. Zeharia A, Eidlitz-Markus T, Haimi-Cohen Y, Samra Z, Kaufman L, Amir J. Management of nontuberculous mycobacteria-induced cervical lymphadenitis with observation alone. Pediatr. Infect. Dis. J. 2008;27:920–922
  19. Winthrop KL, Abrams M, Yakrus M, Schwartz I, Ely J, Gillies D, et al. An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N. Engl. J. Med. 2002;346:1366–1371
  20. Cross JT, Jacobs RF. Other mycobacteria. In: 4th ed..  Feigin RD,  Cherry JD editor. Text-book of Pediatric Infectious Diseases. vol. 4:Philadelphia: W.B. Saunders; 1998;p. 1239–1248
  21. Chao SS, Loh KS, Tan KK, Chong SM. Tuberculous and nontuberculous cervical lymphadenitis: a clinical review. Otolaryngol. Head Neck Surg. 2002;126:176–179
  22. Wu X, Zhang J, Liang J, Lu Y, Li H, Li C, et al. Comparison of three methods for rapid identification of mycobacterial clinical isolates to the species level. J. Clin. Microbiol. 2007;45:1898–1903
  23. Nash KA, Zhang Y, Brown-Elliott BA, Wallace RJ. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J. Antimicrob. Chemother. 2005;55:170–177
  24. Pai M, Riley LW, Colford JM. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 2004;4:761–776
  25. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet. 2000;356:1099–1104
  26. Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GA. Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr. Opin. Pulm. Med. 2005;11:195–202
  27. Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin. Infect. Dis. 2007;45:322–328
  28. Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Raganathan SC. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT. TB in children. PLoS ONE. 2008;3(July (7)):e2624
  29. American Thoracic Society . Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 2000;161(Pt 2):S221–S247
  30. Centers for Disease Control Prevention (CDC) and American Thoracic Society . Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection—United States, 2003. MMWR Morb. Mortal. Wkly. Rep. 2003;52:735–739
  31. American Thoracic Society (CDC) and Infectious Diseases Society of America . Treatment of tuberculosis. MMWR Recomm. Rep. 2003;52(RR-11):1–77

PII: S0165-5876(10)00019-4

doi: 10.1016/j.ijporl.2009.08.029

International Journal of Pediatric Otorhinolaryngology
Volume 74, Issue 4 , Pages 343-346 , April 2010

Article Tools

* Image Usage & Resolution